Huaren Pharmaceutical Co., Ltd.
Status: Publicly traded
Direct answer
Huaren Pharmaceutical Co., Ltd. is publicly traded on SHZ under the ticker 300110.SZ.
Founded in 1998 and headquartered in Qingdao, China, Huaren Pharmaceutical Co., Ltd. is a key player in the Chinese market, primarily focusing on the production and distribution of non-PVC soft bag intravenous solutions. Its comprehensive pharmaceutical offerings include a variety of injectable drugs such as doxofylline, levofloxacin hydrochloride, compound potassium hydrogen phosphate, caffeine citrate, sodium...
Can you invest in Huaren Pharmaceutical Co., Ltd.?
Yes. Huaren Pharmaceutical Co., Ltd. is publicly traded on SHZ under the ticker 300110.SZ.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Huaren Pharmaceutical Co., Ltd.
Detailed equity research is provided by MarketSnap.